News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Teleflex Incorporated (TFX) Releases White Paper on Reducing PICC-Related Infection and Thrombosis


10/14/2013 9:40:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, announces the release of a new white paper to aid clinicians in preventing catheter-related infections and thrombosis. White paper author Nancy Moureau, BSN, RN, CRNI, CPUI, VA-BC, advocates a multi-level preventive approach that includes a controlled release, chlorhexidine-impregnated Peripherally Inserted Central Catheter (PICC) that helps reduce thrombosis and bloodstream infection. The white paper highlights a preliminary report of 88% reduction in bloodstream infections, attributable to use of the ARROW® PICC with Chlorag+ard® Technology, at a major Southern California medical center.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES